Regulation of p53 stability by Mdm2
10.1038/387299a0
Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature, 387(6630), 299–303.

Authors 3
  1. Michael H. G. Kubbutat (first)
  2. Stephen N. Jones (additional)
  3. Karen H. Vousden (additional)
References 30 Referenced 2,664
  1. Bates, S. & Vousden, K. H. p53 in signalling checkpoint arrest or apoptosis. Current Opin. Genet. Dev. 6, 1–7 (1996). (10.1016/S0959-437X(96)90004-0) / Current Opin. Genet. Dev. by S Bates (1996)
  2. Barak, Y. & Oren, M. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11, 2115–2121 (1992). (10.1002/j.1460-2075.1992.tb05270.x) / EMBO J. by Y Barak (1992)
  3. Momand, J., Zambetti, G. P., George, D. L. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237–1245 (1992). (10.1016/0092-8674(92)90644-R) / Cell by J Momand (1992)
  4. Chen, J. D., Marechal, V. & Levine, A. J. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107–4114 (1993). (10.1128/MCB.13.7.4107) / Mol. Cell. Biol. by JD Chen (1993)
  5. Haupt, Y., Barak, Y. & Oren, M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15, 1596–1606 (1996). (10.1002/j.1460-2075.1996.tb00504.x) / EMBO J. by Y Haupt (1996)
  6. Chen, J., Wu, X., Lin, J. & Levine, A. J. mdm-2 inhibits the Gl arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16, 2445–2452 (1996). (10.1128/MCB.16.5.2445) / Mol. Cell. Biol. by J Chen (1996)
  7. Barak, Y., Juven, T., Haffner, R. & Oren, M. mdm-2 expression is induced by wild type p53 activity. EMBO J. 12,461–468 (1993). (10.1002/j.1460-2075.1993.tb05678.x) / EMBO J. by Y Barak (1993)
  8. Wu, X. W., Bayle, J. H., Olson, D. & Levine, A. J. The p53 mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126–1132(1993). (10.1101/gad.7.7a.1126) / Genes Dev. by XW Wu (1993)
  9. Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378, 203–206 (1995). (10.1038/378203a0) / Nature by R Montes de Oca Luna (1995)
  10. Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embyonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206–208 (1995). (10.1038/378206a0) / Nature by SN Jones (1995)
  11. Xiao, Z.-X. et al. Interaction between the retinoblasmoma protein and the oncoprotein MDM2. Nature 375, 694–697 (1995). (10.1038/375694a0) / Nature by Z-X Xiao (1995)
  12. Martin, K. et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691–694 (1995). (10.1038/375691a0) / Nature by K Martin (1995)
  13. Marston, N. J., Crook, T. & Vousden, K. H. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. Oncogene 9, 2707–2716 (1994). / Oncogene by NJ Marston (1994)
  14. Lin, J., Chen, J., Elenbaas, B. & Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235–1246 (1994). (10.1101/gad.8.10.1235) / Genes Dev. by J Lin (1994)
  15. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E. & Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041–5049 (1992). (10.1128/MCB.12.11.5041) / Mol. Cell. Biol. by SP Lees-Miller (1992)
  16. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J. & Howley, P. M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136 (1990). (10.1016/0092-8674(90)90409-8) / Cell by M Scheffner (1990)
  17. Hubbert, N. L., Sedman, S. A. & Schiller, J. T. Human papillomavirus type 16 E6 increases the degradatin rate of p53 in human keratinocytes. J. Virol. 66, 6237–6241 (1992). (10.1128/JVI.66.10.6237-6241.1992) / J. Virol. by NL Hubbert (1992)
  18. Jones, S. N. et al. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc. Natl Acad. Sci. USA 93, 14106–14111 (1996). (10.1073/pnas.93.24.14106) / Proc. Natl Acad. Sci. USA by SN Jones (1996)
  19. Wrede, D., Tidy, J. A., Crook, T., Lane, D. & Vousden, K. H. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol. Carcinog. 4, 171–175 (1991). (10.1002/mc.2940040302) / Mol. Carcinog. by D Wrede (1991)
  20. Maki, C. G., Huibregtse, J. & Howley, P. M. In vivo ubiquitination and proteosome-mediated degradation of p53. Cancer Res. 56, 2649–2654 (1996). / Cancer Res. by CG Maki (1996)
  21. Kubbutat, M. H. G. & Vousden, K. H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell Biol 17, 460–468 (1997). (10.1128/MCB.17.1.460) / Mol. Cell Biol by MHG Kubbutat (1997)
  22. Fenteany, G. et al. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacytin. Science 268, 726–731 (1995). (10.1126/science.7732382) / Science by G Fenteany (1995)
  23. Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857–860 (1993). (10.1038/362857a0) / Nature by JD Oliner (1993)
  24. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296–299 (1997). (10.1038/387296a0) / Nature by Y Haupt (1997)
  25. Di Leonardo, A., Linke, S. P., Clarkin, K. & Wahl, G. M. DNA damage triggers a prolonged p53-dependent Gl arrest and long-term induction of Cipl in normal human fibroblasts. Genes Dev. 8, 2540–2551 (1994). (10.1101/gad.8.21.2540) / Genes Dev. by A Di Leonardo (1994)
  26. Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D. & Levine, A. J. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. Natl Acad. Sci. USA 90, 11623–11627 (1993). (10.1073/pnas.90.24.11623) / Proc. Natl Acad. Sci. USA by ME Perry (1993)
  27. Chen, C. Y. et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl Acad. Sci. USA 91, 2684–2688 (1994). (10.1073/pnas.91.7.2684) / Proc. Natl Acad. Sci. USA by CY Chen (1994)
  28. Marston, N. J. Mutational Analysis of the Tumour Suppressor Protein p53. Thesis, Univ. London (1996). / Mutational Analysis of the Tumour Suppressor Protein p53. by NJ Marston (1996)
  29. Marston, N. J., Jenkins, J. R. & Vousden, K. H. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6. Oncogene 10, 1707–1715 (1995). / Oncogene by NJ Marston (1995)
  30. Rowan, S. et al. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15, 827–838 (1996). (10.1002/j.1460-2075.1996.tb00418.x) / EMBO J. by S Rowan (1996)
Dates
Type When
Created 22 years ago (Aug. 11, 2003, 10:28 p.m.)
Deposited 2 years, 3 months ago (May 17, 2023, 8:11 p.m.)
Indexed 3 days, 14 hours ago (Aug. 24, 2025, 6:50 p.m.)
Issued 28 years, 3 months ago (May 1, 1997)
Published 28 years, 3 months ago (May 1, 1997)
Published Print 28 years, 3 months ago (May 1, 1997)
Funders 0

None

@article{Kubbutat_1997, title={Regulation of p53 stability by Mdm2}, volume={387}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/387299a0}, DOI={10.1038/387299a0}, number={6630}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Kubbutat, Michael H. G. and Jones, Stephen N. and Vousden, Karen H.}, year={1997}, month=may, pages={299–303} }